Vivo Bio Tech informs about updates
Vivo Bio Tech has informed that the Company, has secured a major pre-clinical testing contract valued at ₹10.75 Crores for a novel molecule in collaboration with a leading organization. The details as required under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed as ‘Annexure A’. It attached the copy of the press release in this regard.
The above information is a part of company’s filings submitted to BSE.
